Verona Pharma plc
VRNA
$65.46
$0.681.05%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 18.96% | -16.94% | 58.74% | -6.21% | 5.60% |
Total Receivables | 198.28% | 239.06% | -67.86% | 4.63% | 15.18% |
Inventory | 44.82% | -- | -- | -- | -- |
Prepaid Expenses | -4.91% | 46.59% | 50.00% | 0.14% | 8.55% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -20.56% | 33.66% | 37.39% | -44.28% | -46.75% |
Total Current Assets | 24.52% | -12.50% | 53.14% | -6.17% | 4.77% |
|
|||||
Total Current Assets | 24.52% | -12.50% | 53.14% | -6.17% | 4.77% |
Net Property, Plant & Equipment | 56.09% | -11.64% | -9.54% | -11.98% | 621.36% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 24.21% | -12.05% | 49.74% | -5.91% | 5.35% |
|
|||||
Total Accounts Payable | 64.92% | 64.52% | -10.73% | 33.19% | 324.30% |
Total Accrued Expenses | -2.48% | -6.71% | 137.39% | 130.66% | -51.53% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 89.81% | -7.66% | -7.78% | -5.25% | 213.83% |
Total Finance Division Other Current Liabilities | 533.48% | -92.12% | 3,097.42% | 69.20% | 4.57% |
Total Other Current Liabilities | 533.48% | -92.12% | 3,097.42% | 69.20% | 4.57% |
Total Current Liabilities | 52.70% | -42.19% | 227.24% | 69.97% | -3.55% |
|
|||||
Total Current Liabilities | 52.70% | -42.19% | 227.24% | 69.97% | -3.55% |
Long-Term Debt | 88.12% | 0.27% | 146.54% | 0.36% | 143.02% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -8.01% | -8.73% | -7.86% | -9.63% | 8,775.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 5.90% | -- | -- | -- |
Total Liabilities | 7.30% | -5.46% | 309.48% | 10.34% | 103.34% |
|
|||||
Common Stock & APIC | 16.38% | 0.76% | 2.19% | 0.22% | 0.14% |
Retained Earnings | -6.42% | -8.89% | -17.11% | -6.68% | -3.84% |
Treasury Stock & Other | -15.31% | 6.46% | 1.34% | 3.84% | -14.42% |
Total Common Equity | 56.76% | -22.45% | -25.21% | -9.75% | -5.41% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 56.76% | -22.45% | -25.21% | -9.75% | -5.41% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 56.76% | -22.45% | -25.21% | -9.75% | -5.41% |
|